| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Carcinoma, Non-Small-Cell Lung | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Carcinoma | |||||
| Lung Neoplasms | |||||
| 3 | More general conditions related to this trial | ||||
| Lung Diseases | |||||
| Neoplasms | |||||
| Neoplasms by Histologic Type | |||||
| Neoplasms by Site | |||||
| Neoplasms, Glandular and Epithelial | |||||
| Respiratory Tract Diseases | |||||
| Respiratory Tract Neoplasms | |||||
| Thoracic Neoplasms | |||||
| 4 | Interventions listed in this trial | ||||
| cetuximab | |||||
| paclitaxel | |||||
| carboplatin | |||||
| 5 | More general drug interventions related to this trial | ||||
| Antimitotic Agents | |||||
| Antineoplastic Agents | |||||
| Antineoplastic Agents, Phytogenic | |||||
| Mitosis Modulators | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Pharmacologic Actions | |||||
| Therapeutic Uses | |||||
| Tubulin Modulators | |||||
| 6 | Sponsors listed in this trial | ||||
| ImClone Systems | |||||
| University of Colorado at Denver and Health Sciences Center | |||||
| Greenwich Hospital | |||||
| IUPUI, Indianapolis, IN | |||||
|
